Loading...
HomeMy WebLinkAboutThe Lucknow Sentinel, 2013-12-18, Page 11/41F0 T1 AS December 20 from 12 - 8 Enjoy our Turkey dinner all trimmings and dessert included R Only $1395;HST i Take out available • Call to make reservations,�, afiX evra %.,,,,,.AGF: CA, ilaiMEEDD 590 Campbell St. • 519-812-1777 The uck www.lucknowsentinel.com n 1.50 HST included PM40064683R07656 ow Sentine i Wednesday, December 18, 2013 Christmas Edition online www.Iucknowsentinel.com TROY PATTERSON KINCARDINE NEWS Lucknow Central's Winter Arts Celebration! Lucknow Central Public School had a wide variety of performances during its December Arts Celebration, featuring a variety of Christmas and festive music, skits and performances by all grades on Dec. 11-12, 2013. Mrs. Nelson's Grade 2 class performed 'Our Christmas Alphabet', with some students dressed the part of the letters they were assigned. NEWS Drug trial for Whitechurch family a sign of new hope Garit Reid Grey -Bruce This Week The last 121 weeks for Luke (16) and Zane (14) Braun of Whitechurch have been positive in the eyes of their doctors said their mother Deb- bie Braun has also seen improve- ment in their energy levels. The two teenage brothers are going through a clinical drug trial to help slow the advancement of Morquio A Syn- drome. It's a rare genetic disorder that will shorten their lives. Luke and Zane are missing an enzyme that breaks down complex sugars causing dwarfism, respiratory problems and extreme exhaustion. Approximately 3,000 people are liv- ing with Morquio A Syndrome around the world. The boys are part of a few who are testing the drug, Vimizim, in Can- ada, which was recently sent to the US Food and Drug Administration (FDA) in the US for approval as well as it being sent for approval to Health Canada. Debbie said she has seen a marked improvement in both her sons' energy levels. She said they are able to go through a whole day without having to rest. "All of the different results the doc- tors have come up with for the last 121 weeks have been coming up positive especially from their lung function tests and with their endur- ance levels. Everything is all positive so they have decided to send all of the paperwork off to get approval from the FDA and Health Canada," said Braun. "This drug will slow the progression of the syndrome down and make their lives more manageable." Metabolic geneticist Dr. Julian Raiman said the drug will decrease the amount of sugars in their bodies and will potentially slow down the CONTINUED > PAGE 2